Basic Information
Astellas Pharma is a Japanese pharmaceutical research and development company, primarily engaged in the pharmaceuticals and related products business, operating in more than 70 countries worldwide. The company has approximately 16,000 employees, with core products including the anticancer drugs XTANDI, XOSPATA, and PADCEV; Betanis/Myrbetriq/BETMIGA for overactive bladder (OAB); and Prograf, an immunosuppressant used in organ transplantation.
Astellas Pharma, Inc.
Tokyo,Tokyo,Japan
more than 500 people
January 01, 2005
--